GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
This Quarter Return
+1.81%
1 Year Return
-11.97%
3 Year Return
+36.42%
5 Year Return
+73.97%
10 Year Return
–
AUM
$1.85B
AUM Growth
–
Cap. Flow
+$1.85B
Cap. Flow
% of AUM
99.95%
Top 10 Holdings %
Top 10 Hldgs %
26.1%
Holding
499
New
498
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IBM
IBM
|
$69.1M |
| 2 |
Procter & Gamble
PG
|
$64.3M |
| 3 |
Exxon Mobil
XOM
|
$59.5M |
| 4 |
Johnson & Johnson
JNJ
|
$51.1M |
| 5 |
JPMorgan Chase
JPM
|
$44.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 14.65% |
| 2 | Consumer Staples | 12.02% |
| 3 | Technology | 11.7% |
| 4 | Industrials | 11.31% |
| 5 | Financials | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Target
TGT
$43.6B
| $16.5M | 0.9% |
+240,284
| New | +$16.5M |
|
27
Caterpillar
CAT
$196B
| $16.5M | 0.9% |
+200,425
| New | +$16.5M |
|
28
Vodafone
VOD
$28.8B
| $16.4M | 0.89% |
+571,558
| New | +$16.4M |
|
29
Ecolab
ECL
$78.6B
| $16.3M | 0.89% |
+191,798
| New | +$16.3M |
|
|
EMC
30
DELISTED
EMC CORPORATION
EMC
| $16.2M | 0.88% |
+687,423
| New | +$16.2M |
|
31
Alphabet (Google) Class C
GOOG
$2.58T
| $16M | 0.87% |
+18,204
| New | +$16M |
|
32
SPDR S&P 500 ETF Trust
SPY
$658B
| $15.4M | 0.83% |
+95,899
| New | +$15.4M |
|
33
iShares MSCI Emerging Markets ETF
EEM
$19B
| $15.3M | 0.83% |
+396,972
| New | +$15.3M |
|
34
Boeing
BA
$177B
| $15M | 0.81% |
+145,971
| New | +$15M |
|
35
National Grid
NGG
$70B
| $14.8M | 0.8% |
+261,708
| New | +$14.8M |
|
36
Gilead Sciences
GILD
$140B
| $14.6M | 0.79% |
+284,095
| New | +$14.6M |
|
37
Apple
AAPL
$3.45T
| $14.1M | 0.76% |
+35,578
| New | +$14.1M |
|
|
DD
38
DELISTED
Du Pont De Nemours E I
DD
| $14M | 0.76% |
+266,941
| New | +$14M |
|
39
Berkshire Hathaway Class B
BRK.B
$1.09T
| $13.9M | 0.75% |
+124,030
| New | +$13.9M |
|
|
UN
40
DELISTED
Unilever NV New York Registry Shares
UN
| $13.6M | 0.74% |
+345,835
| New | +$13.6M |
|
41
Philip Morris
PM
$260B
| $13.2M | 0.72% |
+152,570
| New | +$13.2M |
|
42
3M
MMM
$82.8B
| $13M | 0.7% |
+118,959
| New | +$13M |
|
43
Teva Pharmaceuticals
TEVA
$21.1B
| $12.8M | 0.69% |
+327,221
| New | +$12.8M |
|
44
Merck
MRK
$210B
| $12.8M | 0.69% |
+275,137
| New | +$12.8M |
|
45
Pfizer
PFE
$141B
| $12.5M | 0.68% |
+446,071
| New | +$12.5M |
|
46
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $12.2M | 0.66% |
+313,683
| New | +$12.2M |
|
47
McCormick & Company Non-Voting
MKC
$18.9B
| $12.1M | 0.66% |
+172,436
| New | +$12.1M |
|
48
iShares MSCI EAFE ETF
EFA
$66B
| $12M | 0.65% |
+210,026
| New | +$12M |
|
49
AbbVie
ABBV
$372B
| $11.6M | 0.63% |
+281,266
| New | +$11.6M |
|
50
Truist Financial
TFC
$60.4B
| $10.9M | 0.59% |
+321,739
| New | +$10.9M |
|